Guanhao Biotech Hits Day Low of CNY 11.12 Amid Price Pressure

Guanhao Biotech Co., Ltd. experienced a significant decline today, with the stock dropping by 7.22% and reaching an intraday low of CNY 11.12. This performance stands in contrast to the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, Guanhao Biotech has seen a decrease of 2.59%, while its one-month performance shows a modest gain of 4.05%. However, the longer-term outlook remains concerning, with a year-to-date decline of 18.41% and a staggering 75.7% drop over the past decade. The company's financial metrics indicate challenges, including a low Return on Capital Employed (ROCE) of 4.90% and a Return on Equity (ROE) of just 1.25%. Additionally, Guanhao Biotech has reported negative net profit growth of 46.08% in the first half of the year, alongside a significant decline in operating profit over the past five years. With a market capitalization of CNY 3,036 million, the company continues to face hurdles in achieving sustainable growth within the pharmaceuticals and biotechnology sector.